Real-world effectiveness of benralizumab in US subspecialist-treated adults with severe asthma: Findings from CHRONICLE

Reynold A. Panettieri,Njira Lugogo,Wendy C. Moore,Bradley E. Chipps,Brett Jepson,Wenjiong Zhou,Christopher S. Ambrose,Eduardo Genofre,Donna D. Carstens

Respiratory Medicine（2023）

引用 0|浏览9

暂无评分

摘要

•Benralizumab was associated with improved outcomes in severe eosinophilic asthma.•Exacerbation reduction was observed in patients switching from other biologics.•Results reinforce clinical value of benralizumab in the management of patients with severe asthma.

查看译文

关键词

Severe eosinophilic asthma, Noninterventional, Clinical use, Exacerbations, Patient outcomes

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要